Quinidine and Pasireotide: Interaction Details
- Quinidine
- CardioquinCin-QuinDuraquin +6 more
- Pasireotide
- Signifor
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Quinidine and Pasireotide interaction:
Quinidine
- Cardioquin
- Cin-Quin
- Duraquin
- Quinact
- Quinaglute
- Quinalan
- Quinatime
- Quinidex
- Quinora
Pasireotide
- Signifor
We don't have a drug information page for Pasireotide yet. Have a question about Pasireotide? Ask a pharmacist, free →
What Happens When You Take Quinidine With Pasireotide
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
QT-interval prolongation is a known effect of pasireotide. Across 2 studies, the was prolonged at therapeutic as well as supratherapeutic pasireotide doses.
When pasireotide is given together with other agents that lengthen the QT interval, antiarrhythmic drugs among them, their effects on the QT interval may be . When pasireotide is coadministered with other QT-prolonging drugs, monitoring is recommended at baseline and again 21 days after treatment is started.1
The Quinidine and Pasireotide Interaction, Explained
Both quinidine and pasireotide can affect your heart's electrical rhythm. Each one can lengthen a part of the heartbeat called the . Taking them together may add to that effect, which can raise the chance of a serious irregular heart rhythm. This concern is based mostly on how the drugs work, not on reports of harm from this exact pair.
Please keep taking both as prescribed and don't change anything on your own. Your care team may check your heart tracing () before you begin and again about 3 weeks later. Tell them right away if you feel fainting, a racing or pounding heartbeat, or severe dizziness, and ask your pharmacist or doctor if you have questions.
() between quinidine, a class IA antiarrhythmic with known risk, and pasireotide, which prolongs QT at therapeutic and supratherapeutic doses.
- Direction: increased proarrhythmic risk; no PK mechanism is documented.
- Evidence: theoretical (extrapolated from the individual QT effects of each drug).
- Onset: unspecified.
- Management: obtain a baseline and repeat at 21 days after treatment initiation. Correct and , and review other QT-prolonging drugs. Consider whether an alternative is appropriate in patients with additional risk factors (, structural heart disease, congenital long QT).
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Quinidine and Pasireotide Interact
The likely mechanism
How to Manage the Quinidine and Pasireotide Interaction
Your care team can manage this with planned heart monitoring.
- checks: typically a baseline ECG before pasireotide is added, and another about 21 days after starting.
- Individualized plan: your team may monitor you more closely, and your doses may need to be adjusted and individualized by your care team.
- What you can do: keep taking both medicines as prescribed. Tell your pharmacist or prescriber about all other medicines and supplements you use. Report fainting, palpitations, or severe dizziness promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Quinidine or Pasireotide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Quinidine and Pasireotide: Common Questions
How serious is the Quinidine and Pasireotide interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Quinidine and Pasireotide interaction managed?
Your care team can manage this with planned heart monitoring. checks: typically a baseline ECG before pasireotide is added, and another about 21 days after starting. Individualized plan: your team may monitor you more closely, and your doses may need to be adjusted and individualized by your care team. What you can do: keep taking both medicines as prescribed. Tell your pharmacist or prescribe… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Quinidine and Pasireotide Interaction
Ask in your own words about taking Quinidine and Pasireotide together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: SIGNIFOR(R) LAR intramuscular injection suspension, pasireotide intramuscular injection suspension. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2014.
Other Serious Interactions of Quinidine and Pasireotide
Also serious with Quinidine
- ColchicineContraindicated
- Ketoconazole TopicalContraindicated
- LefamulinContraindicated
- DronedaroneContraindicated
Also serious with Pasireotide
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Quinidine
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- American HelleboreMajor
- ArsenicMajor
- BeerMajor
- CesiumMajor
- + 203 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.